This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: Amunix Pharmaceuticals, Inc. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovations of Bryan Irving
Introduction
Bryan Irving is an accomplished inventor based in Woodside, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of targeted therapies.
Latest Patents
One of his notable patents is titled "HER-2 targeted bispecific compositions and methods for making and using the same." This patent discloses polypeptides and methods of making and using such polypeptides. It comprises a bispecific antibody construct covalently linked to an extended recombinant polypeptide. This polypeptide includes a barcode fragment that is releasable upon digestion by a protease, along with a Release Segment that can be proteolytically cleaved. The cleavage releases the bispecific antibody construct from the extended recombinant polypeptide. Bryan Irving holds 1 patent.
Career Highlights
Bryan Irving has established himself as a key figure in the biotechnology sector. He is currently employed at Amunix Pharmaceuticals, Inc., where he continues to innovate and develop new therapeutic solutions.
Collaborations
Throughout his career, Bryan has collaborated with notable professionals in the field, including Volker Schellenberger and Eric Johansen. These collaborations have further enhanced his contributions to biotechnology.
Conclusion
Bryan Irving's work in developing targeted therapies showcases his innovative spirit and dedication to advancing medical science. His contributions are paving the way for new treatment options in the field of biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile